Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
Aurinia Settles Patent Litigation with Teva Business Wire - Wed Aug 19, 3:05PM CDT

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals...

AUPH : 16.16 (+0.69%)
Aurinia: Q2 Earnings Snapshot AP - Thu Aug 6, 7:11AM CDT

Aurinia: Q2 Earnings Snapshot

AUPH : 16.16 (+0.69%)
Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress Business Wire - Thu Aug 6, 7:00AM CDT

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and six months ended June 30, 2026 and provided an update on recent business progress. ...

AUPH : 16.16 (+0.69%)
Aurinia's Guidance Called for Growth Through Year-End: August Will Clarify What That Meant Barchart - Wed Aug 5, 4:03PM CDT

Barchart Research What to Expect from AUPH Earnings AUPH Generated August 5, 2026 Current Price $15.19 EPS Estimate $$0.18 Consensus Rating Moderate Buy Average Move 5.32% Aurinia's Guidance Called for...

AUPH : 16.16 (+0.69%)
AUPH Reports Tomorrow With Analysts Finally Aligned on What Lupus Nephritis Growth Actually Means Barchart - Wed Jul 29, 4:03PM CDT

Barchart Research What to Expect from AUPH Earnings AUPH Generated July 29, 2026 Current Price $15.18 EPS Estimate $$0.18 Consensus Rating Moderate Buy Average Move 5.32% AUPH Reports Tomorrow With Analysts...

AUPH : 16.16 (+0.69%)
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis Business Wire - Mon Jul 6, 7:00AM CDT

— Multitarget Approach Has Potential to Further Improve Outcomes in This Disease Characterized by Continued Unmet Need —

AUPH : 16.16 (+0.69%)
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death Business Wire - Thu Jun 4, 6:00AM CDT

— New Analysis of the AURORA 1 Phase 3 Study Presented at EULAR 2026 Congress —

AUPH : 16.16 (+0.69%)
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences Newsfile - Tue May 19, 7:34AM CDT

Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratulate Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) on the successful completion of its tender offer for...

AUPH : 16.16 (+0.69%)
Aurinia Reports Another Quarter Where LUPKYNIS Does the Talking Barchart - Fri May 8, 4:01PM CDT

Barchart Research What to Expect from AUPH Earnings AUPH Generated May 8, 2026 Current Price $15.23 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 4.54% Aurinia Reports Another Quarter...

AUPH : 16.16 (+0.69%)
Aurinia: Q1 Earnings Snapshot AP - Thu May 7, 7:06AM CDT

Aurinia: Q1 Earnings Snapshot

AUPH : 16.16 (+0.69%)

Barchart Exclusives

Nvidia CEO Jensen Huang Says His $3.5 Billion MediaTek Deal Is ‘Not Circular’ Because ‘They Do Their Own Business’ Barchart - 4 minutes ago
Nvidia just bought $3.5 billion of convertible bonds issued by MediaTek. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.